Pharma major, Sun Pharmaceutical Industries, on Tuesday reported a 286.1 percent year-on-year (YoY) jump in consolidated net profit at Rs 1,241.8 crore for the December 2018 quarter.
In the corresponding quarter last year, the company posted a net profit of Rs 321 crore.
CNBC-TV18 Polls had predicted a profit of Rs 1,064 crore for the quarter under review.
Consolidated total revenue increased 16.3 percent year-on-year to Rs 7,740.2 crore during the quarter under review against Rs 6,653.2 crore in the same period last year.
Consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to Rs 2,153 crore during the quarter under review against Rs 1,453 crore last year.
Shares of Sun Pharma settled at Rs 436.75 apiece, up 2 percent on the BSE.
First Published: IST